47 minutes ago
This Q&A interview highlights several takeaways from the data on upadacitinib in patients with non-segmental vitiligo (NSV).
2 hours ago
Evidence from 3 recent studies explores microbiome modulation, early allergen exposure, and immune tolerance as pathways for food allergy prevention.
3 hours ago
Clinicians discuss diagnostic gaps, treatment strategies, and multidisciplinary care in Wilson disease.
4 hours ago
HS is associated with up to a nearly 2-fold increased risk of heart failure, coronary artery disease, myocardial infarction, venous thromboembolism, and all-cause mortality.
6 hours ago
Bacino highlights the recently approved treatment’s safety data and emphasizes the likelihood of increased adherence due to longer intervals between administration.